{"ok":true,"trend":{"id":756354,"platform":"news","region":"global","key":"immunotherapy startup adecto blames ‘risk-averse funding environment’ for closing down","title":"Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down","url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPZmxLekZrQTBFZUNaamJqdzlMcEsyMHItSVlyWXk5azZRZXNKTXBaY0dsbzREREJqSWxfVkJhU05RR2xvNnVIb0o3RjZGZW45Q1g5clIxUUdTUHVBbjcxUUlPdEM0bnRWQUxfRTlZV3JCSGhQVHVSNGdzOHhmZW9hQWlCajIwYmJUcDVFbjkzOUhWNXlVUklBZ0xHR21yWFhSU1RrbmJzakxZS21WbXYyYnB0MHJsTjdQbXA4VA?oc=5","first_seen":"2026-10-02T16:51:34.869938Z","last_seen":"2026-10-02T18:14:14.657613Z","last_rank":25,"peak_rank":16,"last_volume":null,"peak_volume":0,"seen_count":3,"score":0.9153125,"category_hint":"startups","section":"business","category":"startups","summary":"Adecto, an immunotherapy startup, has closed down and is attributing its collapse to what it calls a risk-averse funding environment. The company's closure adds to a string of biotech shutdowns as investors pull back from early-stage drug development, and it is drawing attention to how difficult conditions have become for clinical-stage startups seeking capital.","why":"It highlights ongoing concerns that tight biotech funding is forcing early-stage companies to shut down.","tone":"negative","entities":["Adecto"],"summarized_at":"2026-10-02T16:52:39.241306Z","meta":{"via":"scan","lang":"en","term":"startup","source":"Fierce Biotech","published":"Fri, 02 Oct 2026 07:53:11 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Immunotherapy startup Adecto shuts down, blaming funding climate","section_name":"Business","category_name":"Startups","timeline":[{"captured_at":"2026-10-02T16:51:34.869938Z","rank":23,"volume":null},{"captured_at":"2026-10-02T17:11:32.452277Z","rank":16,"volume":null},{"captured_at":"2026-10-02T18:14:14.657613Z","rank":25,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPZmxLekZrQTBFZUNaamJqdzlMcEsyMHItSVlyWXk5azZRZXNKTXBaY0dsbzREREJqSWxfVkJhU05RR2xvNnVIb0o3RjZGZW45Q1g5clIxUUdTUHVBbjcxUUlPdEM0bnRWQUxfRTlZV3JCSGhQVHVSNGdzOHhmZW9hQWlCajIwYmJUcDVFbjkzOUhWNXlVUklBZ0xHR21yWFhSU1RrbmJzakxZS21WbXYyYnB0MHJsTjdQbXA4VA?oc=5","author":"Fierce Biotech","title":"Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down","snippet":null,"posted_at":"2026-10-02T07:53:11Z","likes":null}],"elsewhere":[],"window":"7d"}}